Also found in: Medical, Wikipedia.


n. pérdida progresiva de fuerza y masa muscular debida a la vejez.
References in periodicals archive ?
"These findings highlight the importance of body composition by DXA as a promising tool for the evaluation of sarcopenia, body fat, and mortality risk in older adults," the authors write.
Physical activity (in particular resistance exercise) appears to be an effective strategy to counteract sarcopenia, an age-related decline in skeletal muscle mass and strength that can lead to impaired functional capacity and an increased risk of developing chronic metabolic diseases.
Muscle wasting occurs as part of the natural aging process, called sarcopenia, or due to genetic diseases such as muscular dystrophy.
PhaseBio announced it has licensed to ImmunoForge, the global rights for PB1023, a long-acting, recombinant GLP-1 analogue for the treatment of certain diseases, including conditions related to sarcopenia. PB1023 was created as a genetic fusion protein utilizing PhaseBio's proprietary elastin-like polypeptide, or ELP, technology platform.
Insulin resistance plays a significant role in the etiopathogenesis of sarcopenia, which is defined as age-related progressive loss of muscle mass and muscle strength (1-3).
Sarcopenia is the medical term for when both muscle strength and physical performance drop along with muscle mass.
Health officials say age-related muscle and strength loss, or sarcopenia, will affect every man and woman who is not proactively working to prevent it, and what's worse, it will waste away half of one's life.
"We've increased our knowledge about a potential cause of sarcopenia," he said.
Older patients most at risk of falls are those with dementia, poor vision, osteoarthritis, general frailty, sarcopenia, cardiovascular disease, central nervous system diseases and complications from diabetes mellitus and certain prescription drugs, she said.
MIAMI, Fla., February 19, 2019 -- Biopharmaceutical company Longeveron LLC will discussed its latest clinical research of stem cell treatments for aging frailty at the International Conference on Frailty & Sarcopenia Research in February.
Sarcopenia, which is the age-related loss of muscle mass, increases the risk of falls, reduces mobility, functional capacity and is associated with several diseases (Cruz-Jentoft et al., 2010).